CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

The FDA’s new policy limits COVID-19 vaccine eligibility to older adults and high-risk groups, excluding millions from ...

Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...

A Phoenix doctor weighs in on the potential impact of FDA plans to limit COVID booster access to high-risk groups, raising ...

Last month, an average of about 350 people died each week from COVID, according to data from the CDC. With available vaccines and treatments, why are people still dying?

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...